Astrana Health, Inc. announced its financial results for the third quarter ended September 30, 2024, reporting total revenue of $478.71 million. This represents a 38% increase compared to the same period in 2023. Net income attributable to Astrana Health, Inc. for the quarter was $16.099 million, a decrease from $22.059 million in Q3 2023.
Income from operations for the quarter stood at $28.425 million, down from $39.083 million in the prior year's third quarter. The company's President and CEO, Brandon K. Sim, highlighted strong organic and inorganic growth across its businesses, alongside effective cost management and high-quality care delivery.
For the full year 2024, Astrana Health raised its revenue guidance to a range of $1.95 billion to $2.03 billion. The company also narrowed its guidance for net income attributable to Astrana Health, Inc. to $52 million to $58 million, and for Adjusted EBITDA to $165 million to $175 million.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.